Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation (2017)
- Authors:
- USP affiliated authors: PORTO, GECIÂNE SILVEIRA - FEARP ; RUSSO, ELISA MARIA DE SOUSA - FCFRP ; COVAS, DIMAS TADEU - FMRP
- Unidades: FEARP; FCFRP; FMRP
- DOI: 10.1007/s10565-016-9377-2
- Subjects: DIFERENCIAÇÃO CELULAR; CÉLULAS-TRONCO; CÉLULAS SANGUÍNEAS; PATENTE
- Keywords: BLOOD CELLS; CLINICAL TRIALS; HEMATOPOIETIC DIFFERENTIATION; INDUCED PLURIPOTENT STEM CELLS; PATENT LANDSCAPE
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Cell Biology and Toxicology
- ISSN: 0742-2091
- Volume/Número/Paginação/Ano: v. 33, n. 3, p. 233-250, 2017
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
PAES, Bárbara Cristina Martins Fernandes et al. Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation. Cell Biology and Toxicology, v. 33, n. 3, p. 233-250, 2017Tradução . . Disponível em: https://doi.org/10.1007/s10565-016-9377-2. Acesso em: 24 abr. 2024. -
APA
Paes, B. C. M. F., Moço, P. D., Pereira, C. G., Porto, G. S., Russo, E. M. de S., Reis, L. C. J., et al. (2017). Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation. Cell Biology and Toxicology, 33( 3), 233-250. doi:10.1007/s10565-016-9377-2 -
NLM
Paes BCMF, Moço PD, Pereira CG, Porto GS, Russo EM de S, Reis LCJ, Covas DT, Picanço-Castro V. Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation [Internet]. Cell Biology and Toxicology. 2017 ; 33( 3): 233-250.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1007/s10565-016-9377-2 -
Vancouver
Paes BCMF, Moço PD, Pereira CG, Porto GS, Russo EM de S, Reis LCJ, Covas DT, Picanço-Castro V. Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation [Internet]. Cell Biology and Toxicology. 2017 ; 33( 3): 233-250.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1007/s10565-016-9377-2 - Integration pattern of HIV-1 based lentiviral vector carrying recombinant coagulation factor VIII in Sk-Hep and 293T cells
- Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII
- Lentiviral-mediated gene transfer: a patent review
- An enhancer/promoter combination strengthens the expression of blood-coagulation factor VIII in non-viral expression vectors
- Forced expression of OCT4 influences the expression of pluripotent genes in human mesenchymal stem cells and fibroblasts
- Approaches for recombinant human factor IX production in serum-free suspension cultures
- Produção de fator IX recombinante nas células humanas 293T E SK-HEP-1 e avaliação da expressão de genes relacionados à gama-carboxilação
- Pluripotent reprogramming of fibroblasts by lentiviralmediated insertion of SOX2, C-MYC, and TCL-1A
- Murine leukemia virus-derived retroviral vector has differential integration patterns in human cell lines used to produce recombinant factor VIII
- Generation of hyperfunctional recombinant human factor IX variants expressed in human cell line SK-Hep-1
Informações sobre o DOI: 10.1007/s10565-016-9377-2 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas